Tenet Healthcare (NYSE:THC) Lowered to “Buy” Rating by Wall Street Zen

Wall Street Zen lowered shares of Tenet Healthcare (NYSE:THC) from a strong-buy rating to a buy rating in a report published on Monday morning.

Several other research analysts have also issued reports on THC. Leerink Partners upped their target price on Tenet Healthcare from $255.00 to $264.00 and gave the company an “outperform” rating in a research report on Friday, February 20th. Wells Fargo & Company reduced their target price on Tenet Healthcare from $265.00 to $213.00 and set an “overweight” rating on the stock in a research report on Friday, May 1st. Robert W. Baird reduced their target price on Tenet Healthcare from $245.00 to $210.00 and set a “neutral” rating on the stock in a research report on Tuesday, May 5th. Royal Bank Of Canada dropped their price target on Tenet Healthcare from $277.00 to $236.00 and set an “outperform” rating on the stock in a research note on Friday, May 1st. Finally, KeyCorp dropped their price target on Tenet Healthcare from $250.00 to $225.00 and set an “overweight” rating on the stock in a research note on Friday, May 1st. Nineteen investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $244.16.

Tenet Healthcare Trading Up 0.6%

THC opened at $191.50 on Monday. The firm has a market cap of $16.50 billion, a price-to-earnings ratio of 9.96, a PEG ratio of 1.27 and a beta of 1.30. The company has a current ratio of 1.36, a quick ratio of 1.30 and a debt-to-equity ratio of 1.96. Tenet Healthcare has a 12 month low of $146.60 and a 12 month high of $247.21. The stock has a fifty day moving average price of $202.90 and a 200-day moving average price of $204.02.

Tenet Healthcare (NYSE:THC) last released its quarterly earnings results on Thursday, April 30th. The company reported $4.82 EPS for the quarter, topping the consensus estimate of $4.21 by $0.61. The firm had revenue of $5.37 billion during the quarter, compared to analyst estimates of $5.39 billion. Tenet Healthcare had a return on equity of 25.55% and a net margin of 7.94%.The business’s revenue for the quarter was up 2.6% compared to the same quarter last year. During the same period in the previous year, the company posted $4.36 EPS. Tenet Healthcare has set its FY 2026 guidance at 16.380-18.68 EPS. As a group, equities research analysts anticipate that Tenet Healthcare will post 17.56 earnings per share for the current fiscal year.

Insider Buying and Selling at Tenet Healthcare

In related news, EVP Thomas W. Arnst sold 24,000 shares of the stock in a transaction that occurred on Monday, March 2nd. The stock was sold at an average price of $234.04, for a total value of $5,616,960.00. Following the completion of the sale, the executive vice president owned 8,012 shares of the company’s stock, valued at approximately $1,875,128.48. This trade represents a 74.97% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Paola M. Arbour sold 6,500 shares of the stock in a transaction that occurred on Wednesday, March 11th. The shares were sold at an average price of $238.43, for a total value of $1,549,795.00. Following the completion of the sale, the executive vice president directly owned 29,291 shares of the company’s stock, valued at approximately $6,983,853.13. This represents a 18.16% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 46,517 shares of company stock valued at $10,943,111 over the last quarter. 0.81% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Tenet Healthcare

Several hedge funds and other institutional investors have recently made changes to their positions in the stock. PNC Financial Services Group Inc. grew its position in Tenet Healthcare by 10.5% in the first quarter. PNC Financial Services Group Inc. now owns 6,086 shares of the company’s stock worth $1,148,000 after acquiring an additional 580 shares during the period. Parallel Advisors LLC grew its position in Tenet Healthcare by 108.9% in the first quarter. Parallel Advisors LLC now owns 1,389 shares of the company’s stock worth $262,000 after acquiring an additional 724 shares during the period. Hanseatic Management Services Inc. purchased a new position in Tenet Healthcare in the first quarter worth approximately $326,000. AIA Group Ltd purchased a new position in Tenet Healthcare in the first quarter worth approximately $1,405,000. Finally, Dorsey Wright & Associates grew its position in Tenet Healthcare by 29.4% in the first quarter. Dorsey Wright & Associates now owns 69,990 shares of the company’s stock worth $13,208,000 after acquiring an additional 15,895 shares during the period. Institutional investors and hedge funds own 95.44% of the company’s stock.

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.